{
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "verification_stats": {
    "total_snippets": 3,
    "verified": 3,
    "failed": 0,
    "modified": 0
  },
  "verified_snippets": [
    {
      "id": 1,
      "quote": "Flublok contains recombinant HAproteins of the three strains of influenza virus specified by health authorities for inclusion in the annual seasonal vaccine. These proteins function as antigens which induce a humoral immune response, measured by hemagglutination hibiti (HI) tib d ) requirements. For the2024-2025influenzaseasonit is formulatedtocontain135mcgHA per 0.5mLdose, with45mcgHAof eachof thefollowing3influenzavirusstrains:A/West Virginia/30/2022 (A/Wisconsin/67/2022 pdm09-like virus) (H1N1), A/Massachusetts/18/ 2022 (H3N2) and B/Austria/1359417/2021.",
      "relevance_explanation": "This quote directly states that Flublok contains recombinant HA proteins of the three strains of influenza virus specified by health authorities for inclusion in the annual seasonal vaccine. This means the antigens in Flublok are identical to those selected by the WHO and FDA for that flu season, supporting the claim of an identical antigenic match.",
      "context": "12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action Flublok contains recombinant HAproteins of the three strains of influenza virus specified by health authorities for inclusion in the annual seasonal vaccine. These proteins function as antigens which induce a humoral immune response, measured by hemagglutination hibiti (HI) tib d ) requirements. For the2024-2025influenzaseasonit is formulatedtocontain135mcgHA per 0.5mLdose, with45mcgHAof eachof thefollowing3influenzavirusstrains:A/West Virginia/30/2022 (A/Wisconsin/67/2022 pdm09-like virus) (H1N1), A/Massachusetts/18/ 2022 (H3N2) and B/Austria/1359417/2021.",
      "location": {
        "start": 16174,
        "end": 16737,
        "page_index": 2,
        "page_number": 3
      }
    },
    {
      "id": 2,
      "quote": "Flublok is standardized according to United States Public Health Service (USPHS) [ ] j g hemagglutinin(HA) proteinsfromthreeinfluenzavirusesfor intramuscular use. It contains purifiedHAproteins producedinacontinuous insect cell line(expresSF+\u00ae) that is derived rom Sf9 cells of the fall armyworm, Spodoptera frugiperda (which is related to moths, caterpillars and butterflies), and grown in serum-free medium composed of chemicallydefined lipids, vitamins, amino acids, and mineral salts. Each of the three HAs is manufactured using the same process and have overlapping compositions.",
      "relevance_explanation": "This quote explains that Flublok is standardized according to USPHS requirements and contains hemagglutinin proteins from three influenza viruses, which are the strains selected for the vaccine each year. This supports the claim that Flublok ensures an identical antigenic match with the strains selected by health authorities (WHO and FDA).",
      "context": "xpressed in this cell line using a baculovirus vector (Autographa californica nuclear olyhedrosis virus), extracted from the cells with Triton X-100 and further purified by olumn chromatography. The purified HAs are then blended and filled into single-dose yringes. Flublok is standardized according to United States Public Health Service (USPHS) [ ] j g hemagglutinin(HA) proteinsfromthreeinfluenzavirusesfor intramuscular use. It contains purifiedHAproteins producedinacontinuous insect cell line(expresSF+\u00ae) that is derived rom Sf9 cells of the fall armyworm, Spodoptera frugiperda (which is related to moths, caterpillars and butterflies), and grown in serum-free medium composed of chemicallydefined lipids, vitamins, amino acids, and mineral salts. Each of the three HAs is manufactured using the same process and have overlapping compositions.",
      "location": {
        "start": 17475,
        "end": 18059,
        "page_index": 2,
        "page_number": 3
      }
    },
    {
      "id": 3,
      "quote": "Description (11)]. 5 WARNINGS AND PRECAUTIONS 5.1 Managing Allergic Reactions Appropriate medical treatment must be immediately available to manage potentia g dminister Flublok as a single 0.5 mL dose. 2 Administration [Table: [TABLE 4 - See table_p1_ff89f192.png]] 2 DOSAGE AND ADMINISTRA 2.1 Dosage FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE DOSAGE AND ADMINISTRATION ------------ CONTRAINDICATIONS ------------ \u2022 Do not administer Flublok to anyone with a history of severe allergic reactions (e.g., anaphylaxis) to any component of the vaccine. (4, 6.2, 11) ---------- WARNINGS AND PRECAUTIONS ---------- or intramuscular use (0.5 mL). (2) --------- DOSAGE FORMS AND ublok is an injection a single dose is 05mL vaccine. Flublok is approved for use in persons 18 years of age and older. (1) ---------- DOSAGE AND ADMINISTRATION ---------- For intramuscular use (05 mL) (2) Initial U.S. Approval: 2013 ----------- INDICATIONS AND USAGE ----------- Flublok is a vaccine indicated for active immunization for the prevention of disease HIGHLIGHTS OF PRESCRIBING INFORMATION Thesehighlightsdonot includeall theinformationneededtouseFlublok\u00aesafely and effectively. See full prescribing information for Flublok. Flublok (Influenza Vaccine) njection for Intramuscular Use 2024-2025 Formula data for Flublok are presented fromfour clinical trials (Studies 1, 2, 3, and 4). Data a placebo-controlled trial in adults 18 through 49 years of age (Study 1) are nted, followed by data pooled according to age group fromStudies 2 and 4 (adults ough 64 years of age) and Studies 3 and 4 (adults aged 65 years and older).",
      "relevance_explanation": "This section includes the statement 'Flublok is a vaccine indicated for active immunization for the prevention of disease' and references the 2024-2025 formula, which is based on the strains selected for that season. This context supports the claim that Flublok is formulated to match the strains selected by health authorities (WHO and FDA) each year.",
      "context": "Description (11)]. 5 WARNINGS AND PRECAUTIONS 5.1 Managing Allergic Reactions Appropriate medical treatment must be immediately available to manage potentia g dminister Flublok as a single 0.5 mL dose. 2 Administration [Table: [TABLE 4 - See table_p1_ff89f192.png]] 2 DOSAGE AND ADMINISTRA 2.1 Dosage FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE DOSAGE AND ADMINISTRATION ------------ CONTRAINDICATIONS ------------ \u2022 Do not administer Flublok to anyone with a history of severe allergic reactions (e.g., anaphylaxis) to any component of the vaccine. (4, 6.2, 11) ---------- WARNINGS AND PRECAUTIONS ---------- or intramuscular use (0.5 mL). (2) --------- DOSAGE FORMS AND ublok is an injection a single dose is 05mL vaccine. Flublok is approved for use in persons 18 years of age and older. (1) ---------- DOSAGE AND ADMINISTRATION ---------- For intramuscular use (05 mL) (2) Initial U.S. Approval: 2013 ----------- INDICATIONS AND USAGE ----------- Flublok is a vaccine indicated for active immunization for the prevention of disease HIGHLIGHTS OF PRESCRIBING INFORMATION Thesehighlightsdonot includeall theinformationneededtouseFlublok\u00aesafely and effectively. See full prescribing information for Flublok. Flublok (Influenza Vaccine) njection for Intramuscular Use 2024-2025 Formula data for Flublok are presented fromfour clinical trials (Studies 1, 2, 3, and 4). Data a placebo-controlled trial in adults 18 through 49 years of age (Study 1) are nted, followed by data pooled according to age group fromStudies 2 and 4 (adults ough 64 years of age) and Studies 3 and 4 (adults aged 65 years and older).",
      "location": {
        "start": 430,
        "end": 2057,
        "page_index": null,
        "page_number": null
      }
    }
  ],
  "failed_snippets": []
}